Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6^th:

MAIA Biotechnology, Inc. (MAIA Quick QuoteMAIA - Free Report) : This immuno-oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.4% over the last 60 days.

MAIA Biotechnology, Inc. Price and Consensus

MAIA Biotechnology, Inc. price-consensus-chart | MAIA Biotechnology, Inc. Quote

MAIA’s shares gained 0.5% over the last three months compared with the S&P 500’s decline of 5.6%. The company possesses a Momentum Score  of A.

MAIA Biotechnology, Inc. Price

MAIA Biotechnology, Inc. price | MAIA Biotechnology, Inc. Quote

Byrna Technologies Inc. (BYRN Quick QuoteBYRN - Free Report) : This non-lethal defense technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 25% overthe last 60 days.

Byrna Technologies Inc. Price and Consensus

Byrna Technologies Inc. price-consensus-chart | Byrna Technologies Inc. Quote

Byrna’s shares gained 33.8% over the last six months compared with the S&P 500’s decline of 4.7%. The company possesses a Momentum Score of B.

Byrna Technologies Inc. Price

Byrna Technologies Inc. price | Byrna Technologies Inc. Quote

OncoCyte Corporation : This precision diagnostics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 39.3% over the last 60 days.

OncoCyte Corporation Price and Consensus

OncoCyte Corporation price-consensus-chart | OncoCyte Corporation Quote

OncoCyte’s shares gained 45.3% over the last three months compared with the S&P 500’s decline of 5.6%. The company possesses a Momentum Score of B.

OncoCyte Corporation Price

OncoCyte Corporation price | OncoCyte Corporation Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.